ClinicalTrials.gg
RecruitingNCT06806514Updated Jun 2, 2025

The Relationship Between Upper Extremity Exercise Capacity, Respiratory and Peripheral Muscle Strength in Chronic Low Back Pain

An observational study in Chronic Low Back Pain, sponsored by Kirsehir Ahi Evran Universitesi. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-06-02.

Sponsored by Kirsehir Ahi Evran Universitesi · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Feb 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
47
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi — 5 open to participants now, 5 under way, none of them phase 3. Low Back Pain · Kirsehir Ahi Evran Universitesi.

Started
2025
with 3 others
Observational
4 of 13
2 open now
Registered
5th of 13
by date

Among the 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi, this one is one of 4 that started in 2025, is one of 4 observational ones, and was the 5th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

5 of the 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Low Back Pain by Kirsehir Ahi Evran Universitesi, or all of them as a file.
02

Study summary

The aim of the study was to evaluate the upper extremity exercise capacity of individuals with chronic low back pain and to investigate its relationship with respiratory muscle strength, peripheral muscle strength, chest expansion, pain, disability level, fear of movement and quality of life.

03

Conditions studied

  • Chronic Low Back Pain

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals with chronic low back pain who are being followed up at the Department of Physical Medicine and Rehabilitation at Kirsehir Ahi Evran University will be included in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntary participation in the study
  • Being aged 18-65
  • Chronic low back pain for at least the last 3 months
  • Pain intensity according to Visual Analogue Scale (VAS) ≥3

Exclusion criteria

Exclusion Criteria:

  • History of cancer
  • Presence of spinal infection
  • Presence of rheumatological disorders
  • Presence of spinal fracture
  • Red flag signs
  • Having a psychological disorder
  • Presence of spinal surgery
  • Having radiculopathy
  • Presence of anatomical and congenital abnormalities
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
47 participants (estimated)
Patient registry
No

Groups and cohorts

  • Indıviduals with chronic low back pain
06

What researchers measure

Primary outcomes

  1. Upper extremity exercise capacity

    It will be assessed by 6 minute pegboard and ring test.

    Time frame: 1st day

  2. Respiratory muscle strength

    Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) will be measured using a portable mouth pressure device.

    Time frame: 1st day

  3. Peripheral muscle strength

    Knee extensor, shoulder abductor and hand grip strength will be evaluated with a dynamometer.

    Time frame: 1st day

  4. Chest expansion

    Neutral, deep inspiration and deep expiration circumferences will be measured from the axillary, epigastric and subcostal regions using a tape measure.

    Time frame: 1st day

  5. Disability level

    It will be assessed with Oswestry Disability Index. High scores on the scale indicate the presence and severity of symptoms.

    Time frame: 1st day

Secondary outcomes

  1. Kinesiophobia

    It will be evaluated with the Tampa Kinesiophobia scale.The total score ranges from 17-68, with a score above 37 indicating a high degree of kinesiophobia.

    Time frame: 1st day

  2. Quality of life

    It will be evaluated with the Short Form-12 Quality of Life scale.The subscales rate health from 0 to 100, with 0 indicating poor health and 100 indicating good health.

    Time frame: 1st day

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2025 (actual). Primary completion is estimated for Dec 2025, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2025
First posted
Feb 4, 2025
StartActual
Feb 3, 2025
Primary completionEst.
Dec 2025
CompletionEst.
May 2026
Last update
Jun 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06806514
Responsible party
Merve Firat (Assistant Professor, Kirsehir Ahi Evran Universitesi) — Principal investigator
First posted
Feb 4, 2025
Start date
Feb 3, 2025
Primary completion
Dec 2025 (estimated)
Completion
May 2026 (estimated)
Last update
Jun 2, 2025

Study contacts

Merve Firat
Contact
mervefirat@ahievran.edu.tr
+90 850 441 02 44 ext. 2490

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion